About Erik Halvorsen

Erik Halvorsen attended the University of Virginia where he earned his B.A. in Psychology/Pre-Med. He then received his M.S. in Anatomy from the Virginia Commonwealth University School of Medicine, before completing his Ph.D. in Neuropharmacology in only 4.5 years at the University of Virginia researching new drugs for Parkinson’s Disease. During his studies, Erik found a love for research and innovation and learned how long and arduous the path of translating discoveries to new treatments that can help patients.

For almost 14 years in Boston, Erik led numerous teams focused on life sciences R&D across the Harvard system—working with some of the top pharmaceutical, medical device, and diagnostics companies in the country and partnering with investors to build new companies. Among some of the more notable start-ups that Erik has served as a strategic advisor or board member is Tetraphase Pharmaceuticals (NASDAQ—TTPH), Claritas Genomics, OPENPediatrics, Jibo, and FAR Biotechnology.

After nearly 15 years in Boston, Erik was recruited to become the first Director of Innovation for the Texas Medical Center, the largest medical center in the country including leading institutions like MD Anderson Cancer Center, Texas Children’s Hospital, Baylor College of Medicine, Methodist Hospital and Rice University.

Currently, Erik serves as a Partner at pHpartners. This boutique healthcare investment company partners with leading businesses in therapeutics, digital health technology, and more. In his current role, Erik focuses on assisting innovative healthcare companies to secure capital and strategic partnerships to deliver better treatments to patients. Erik and his team have driven maximum value for their clients through capital raises, M&A, partnerships, and strategic advisory services. A few of these notable companies include Pfizer, Orion Health, Climatec, and more.

Erik Halvorsen currently lives in Houston, Texas with his wife and two children (Dylan and Hunter). In his spare time, he enjoys playing golf and traveling with his family. He continues to consult with cutting-edge healthcare startups, investors and hospitals to bring new products to market that improve patient lives and transform healthcare.